Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Heart attack; This is a spontaneous report from a contactable consumer (patient''s daughter). A 70-year-old male patient received first dose of BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, strength: 0.3 ml, Lot number: EP2166, expiration date: unknown) via an unspecified route of administration (location: Left arm) on 23Feb2021 at 10:00 AM at age of 70-year-old at 0.3 mL, single for COVID-19 immunisation. The patient''s medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The vaccine was administered at other facility. The patient didn''t receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included atorvastatin, metformin, and indapamide/ perindopril arginine (PRETERAX). The patient experienced heart attack on 28Feb2021 at 09:00 AM, seriousness criteria was reported as resulting to death. The patient didn''t receive any treatment for the event. Since the vaccination, he was not tested for COVID-19. The patient died on 28Feb2021 at 9:00 AM. The cause of death was reported as heart attack. An autopsy was not performed.; Reported Cause(s) of Death: Heart attack
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166